Home/KeyZell/José del Corral
JD

José del Corral

Chief Executive Officer (CEO)

KeyZell

Therapeutic Areas

KeyZell Pipeline

DrugIndicationPhase
LZ-167Oncology (specific indications not disclosed)Pre-clinical